{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:28:38Z","timestamp":1786721318283,"version":"build-2736575974"},"reference-count":74,"publisher":"American Chemical Society (ACS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI114114"],"award-info":[{"award-number":["AI114114"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM097917"],"award-info":[{"award-number":["GM097917"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM100607"],"award-info":[{"award-number":["GM100607"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Staphylococcus aureus is a leading cause of antibiotic-resistant infections worldwide. Therefore, there is a constant need to develop new growth inhibitors. Pentamidine analogs (PAs) composed of thiourea-linked amidines were evaluated for activity against methicillin-resistant S. aureus (MRSA) and other Gram-positive bacteria. S. aureus, MRSA, Staphylococcus epidermidis, Streptococcus pyogenes, Mycobacterium, and Bacillus were highly susceptible with minimal inhibitory concentration (MIC) values ranging from 1.56 to 6.25 \u03bcM, whereas Enterococcus species and Clostridioides difficile were not as susceptible with MICs of 50 to \u2265100 \u03bcM. For S. aureus, MRSA and VISA strains, PAs showed \u223c4-fold lower MICs when compared to pentamidine (PNT). The concentration of PAs needed to lyse 50% of red blood cells (HC50) was \u223c16\u201332-fold higher than their corresponding MICs. For PNT, a lower HC50\/MIC range of 1.25\u20135 was observed. Approximately 60% of MRSA was cleared from infected Caenorhabditis elegans by the PAs. PAs also provided 100% protection in a septicemia model of infected mice. Morphological changes induced by these compounds indicate disruption of cell membrane integrity, where &amp;gt;80% of treated bacterial cells took up propidium iodide in a permeation assay. Importantly, there was a lack of resistance observed with the PAs, compared to the fairly rapid and stable resistance occurrence for drugs commonly used to treat S. aureus infection. These results reflect the potential of such compounds as potential new tools to optimize and combat the menace of drug-resistant S. aureus.<\/jats:p>","DOI":"10.1021\/acsinfecdis.6c00572","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T04:01:15Z","timestamp":1785988875000},"page":"2874-2891","source":"Crossref","is-referenced-by-count":0,"title":["Activity of\nThiourea-Linked Diamidines against Multidrug-Resistant\n                    <i>Staphylococcus aureus<\/i>"],"prefix":"10.1021","volume":"12","author":[{"given":"Yi","family":"Jin","sequence":"first","affiliation":[{"name":"Clemson University , , , ,","place":["Clemson, South Carolina, United States, 29634"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Story","sequence":"additional","affiliation":[{"name":"NUBAD, LLC , , ,","place":["Greenville, South Carolina, United States, 29605"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Chamberlin","sequence":"additional","affiliation":[{"name":"Clemson University , , , ,","place":["Clemson, South Carolina, United States, 29634"]},{"name":"NUBAD, LLC , , ,","place":["Greenville, South Carolina, United States, 29605"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5873-1066","authenticated-orcid":true,"given":"Dev P.","family":"Arya","sequence":"additional","affiliation":[{"name":"Clemson University , , , ,","place":["Clemson, South Carolina, United States, 29634"]},{"name":"NUBAD, LLC , , ,","place":["Greenville, South Carolina, United States, 29605"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"issue":"15","key":"2026081410080010500_cit1","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections in\nthe United States","volume":"298","author":"Klevens","year":"2007","journal-title":"JAMA"},{"issue":"21","key":"2026081410080010500_cit2","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1001\/jamainternmed.2013.10423","article-title":"National burden\nof invasive methicillin-resistant Staphylococcus aureus infections,\nUnited States, 2011","volume":"173","author":"Dantes","year":"2013","journal-title":"JAMA Intern. Med."},{"issue":"9","key":"2026081410080010500_cit3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro2200","article-title":"Waves of resistance:\nStaphylococcus aureus in the antibiotic\nera","volume":"7","author":"Chambers","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"issue":"11","key":"2026081410080010500_cit4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic\nmonitoring of vancomycin for serious methicillin-resistant\nStaphylococcus aureus infections: a revised consensus guideline and\nreview by the American Society of Health-System Pharmacists, the Infectious\nDiseases Society of America, the Pediatric Infectious Diseases Society,\nand the Society of Infectious Diseases Pharmacists","volume":"77","author":"Rybak","year":"2020","journal-title":"Am. J. Health-Syst. Pharm."},{"issue":"1","key":"2026081410080010500_cit5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69058-z","article-title":"Global prevalence and distribution\nof vancomycin resistant, vancomycin intermediate and heterogeneously\nvancomycin intermediate Staphylococcus aureus clinical isolates: a\nsystematic review and meta-analysis","volume":"10","author":"Shariati","year":"2020","journal-title":"Sci. Rep."},{"key":"2026081410080010500_cit6","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-021-00967-y","article-title":"Systematic review and\nmeta-analysis\nof the epidemiology of vancomycin-resistance Staphylococcus aureus\nisolates","volume":"10","author":"Wu","year":"2021","journal-title":"Antimicrob. Resist. Infect. Control"},{"issue":"2","key":"2026081410080010500_cit7","first-page":"269","article-title":"Vancomycin resistance in Staphylococcus\naureus","volume":"90","author":"McGuinness","year":"2017","journal-title":"Yale J. Biol. Med."},{"issue":"6797","key":"2026081410080010500_cit8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/35021219","article-title":"Molecular\nmechanisms that confer antibacterial drug resistance","volume":"406","author":"Walsh","year":"2000","journal-title":"Nature"},{"issue":"1","key":"2026081410080010500_cit9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for\nbad bugs: confronting the challenges of antibacterial discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"6","key":"2026081410080010500_cit10","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1093\/jac\/dkm357","article-title":"Polymyxin B for\nthe treatment of multidrug-resistant pathogens: a critical review","volume":"60","author":"Zavascki","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"issue":"11","key":"2026081410080010500_cit11","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1021\/jm000413a","article-title":"Diguanidino and\n\u201creversed\u201d diamidino 2, 5-diarylfurans as antimicrobial\nagents","volume":"44","author":"Stephens","year":"2001","journal-title":"J. Med. Chem."},{"issue":"4","key":"2026081410080010500_cit12","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/antibiotics12040742","article-title":"New Antibiotics for Staphylococcus aureus Infection:\nAn Update from the World Association of Infectious Diseases and Immunological\nDisorders (WAidid) and the Italian Society of Anti-Infective Therapy\n(SITA)","volume":"12","author":"Esposito","year":"2023","journal-title":"Antibiotics"},{"issue":"26","key":"2026081410080010500_cit13","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.2174\/0929867329666220314121446","article-title":"Ninety Years of Pentamidine:\nThe Development and Applications of Pentamidine and its Analogs","volume":"29","author":"Zhang","year":"2022","journal-title":"Curr. Med. Chem."},{"key":"2026081410080010500_cit14","first-page":"459","article-title":"Aerosolized\npentamidine for treatment and prophylaxis\nof Pneumocystis carinii pneumonia in\npatients with acquired immunodeficiency syndrome","volume":"134","author":"Hickey","year":"2004","journal-title":"Drugs Pharm. Sci."},{"issue":"10","key":"2026081410080010500_cit15","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/cbdv.200590111","article-title":"Pentamidine\nis an antiparasitic and apoptotic drug that selectively modifies ubiquitin","volume":"2","author":"Nguewa","year":"2005","journal-title":"Chem. Biodivers."},{"key":"2026081410080010500_cit16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00436-002-0799-9","article-title":"Arsenicals\n(melarsoprol), pentamidine and suramin in the treatment of human African\ntrypanosomiasis","volume":"90","author":"Nok","year":"2003","journal-title":"Parasitol. Res."},{"issue":"6","key":"2026081410080010500_cit17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10156-004-0348-9","article-title":"Challenges\nand new discoveries in the treatment of\nleishmaniasis","volume":"10","author":"Singh","year":"2004","journal-title":"J. Infect. Chemother."},{"issue":"2","key":"2026081410080010500_cit18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2\ncell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically\nproven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"8","key":"2026081410080010500_cit19","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1099\/vir.0.000201","article-title":"Viroporins: structure,\nfunction and potential as antiviral\ntargets","volume":"96","author":"Scott","year":"2015","journal-title":"J. Gen. Virol."},{"issue":"5","key":"2026081410080010500_cit20","doi-asserted-by":"publisher","first-page":"782","DOI":"10.7326\/0003-4819-103-5-782","article-title":"Pentamidine for\nthe treatment of Pneumocystis carinii\npneumonia and other protozoal diseases","volume":"103","author":"Pearson","year":"1985","journal-title":"Ann.\nIntern. Med."},{"issue":"7","key":"2026081410080010500_cit21","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1016\/j.ejmech.2011.04.001","article-title":"Novel pentamidine\nderivatives: Synthesis, anti-tumor properties and polynucleotide-binding\nactivities","volume":"46","author":"Jarak","year":"2011","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"2026081410080010500_cit22","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1128\/AAC.47.10.3252-3259.2003","article-title":"Pentamidine\nis active in vitro against Fusarium species","volume":"47","author":"Lionakis","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"2026081410080010500_cit23","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1099\/jmm.0.000301","article-title":"In vitro\nsynergistic combinations\nof pentamidine, polymyxin B, tigecycline and tobramycin with antifungal\nagents against Fusarium spp","volume":"65","author":"Venturini","year":"2016","journal-title":"J. Med. Microbiol."},{"issue":"46","key":"2026081410080010500_cit24","doi-asserted-by":"publisher","first-page":"13576","DOI":"10.1021\/bi034852y","article-title":"Cooperative dimerization\nof a heterocyclic diamidine determines sequence-specific DNA recognition","volume":"42","author":"Tanious","year":"2003","journal-title":"Biochemistry"},{"issue":"14","key":"2026081410080010500_cit25","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1002\/chem.201406322","article-title":"Resolution of Mixed\nSite DNA Complexes with Dimer-Forming\nMinor-Groove Binders by Using Electrospray Ionization Mass Spectrometry:\nCompound Structure and DNA Sequence Effects","volume":"21","author":"Laughlin","year":"2015","journal-title":"Chem. \u2013 Eur. J."},{"issue":"39","key":"2026081410080010500_cit26","doi-asserted-by":"publisher","first-page":"11107","DOI":"10.1039\/c1cc13355a","article-title":"Light-controlled\nDNA binding of bisbenzamidines","volume":"47","author":"Sa\u0301nchez","year":"2011","journal-title":"Chem. Commun."},{"issue":"5","key":"2026081410080010500_cit27","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1093\/nar\/gkm1180","article-title":"Pentamidine binds to\ntRNA through non-specific hydrophobic interactions\nand inhibits aminoacylation and translation","volume":"36","author":"Sun","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"2026081410080010500_cit28","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1080\/14756366.2018.1484733","article-title":"Synthesis, anti-bacterial and anti-protozoal\nactivities of amidinobenzimidazole derivatives and their interactions\nwith DNA and RNA","volume":"33","author":"Bistrovic\u0301","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"2026081410080010500_cit29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1039\/C8MD00425K","article-title":"Recent developments in compounds\nacting in the DNA minor groove","volume":"10","author":"Rahman","year":"2019","journal-title":"MedChemComm"},{"issue":"7","key":"2026081410080010500_cit30","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3390\/ph16071040","article-title":"Small Molecules\nIncorporating Privileged Amidine Moiety\nas Potential Hits Combating Antibiotic-Resistant Bacteria","volume":"16","author":"El-Sayed","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"5","key":"2026081410080010500_cit31","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3390\/v15051171","article-title":"In Silico and In\nVitro Evaluation of Some Amidine Derivatives as Hit Compounds towards\nDevelopment of Inhibitors against Coronavirus Diseases","volume":"15","author":"Hassan","year":"2023","journal-title":"Viruses"},{"issue":"5","key":"2026081410080010500_cit32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S1471-4922(03)00069-2","article-title":"Pentamidine\nuptake and resistance in pathogenic protozoa: past, present and future","volume":"19","author":"Bray","year":"2003","journal-title":"Trends Parasitol."},{"issue":"3","key":"2026081410080010500_cit33","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1073\/pnas.87.3.950","article-title":"Selective cleavage\nof kinetoplast DNA minicircles promoted\nby antitrypanosomal drugs","volume":"87","author":"Shapiro","year":"1990","journal-title":"Proc. Natl. Acad.\nSci. U.S.A."},{"issue":"2","key":"2026081410080010500_cit34","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1128\/jb.73.2.172-177.1957","article-title":"Effect of pentamidine on the growth of Escherichia coli","volume":"73","author":"Amos","year":"1957","journal-title":"J. Bacteriol."},{"issue":"4","key":"2026081410080010500_cit35","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ijantimicag.2010.05.017","article-title":"Pentamidine inhibits\nCoxiella burnetii growth and 23S rRNA intron splicing in vitro","volume":"36","author":"Minnick","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"7\u20138","key":"2026081410080010500_cit36","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0223-5234(00)80032-X","article-title":"In vitro antimicrobial\nactivity of aromatic diamidines\nand diimidazolines related to pentamidine","volume":"34","author":"Donkor","year":"1999","journal-title":"Eur.\nJ. Med. Chem."},{"key":"2026081410080010500_cit37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105175","article-title":"Benzimidazole\nanalogues as efficient arsenals in war against methicillin-resistance\nstaphylococcus aureus (MRSA) and its SAR studies","volume":"115","author":"Zha","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"13","key":"2026081410080010500_cit38","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1016\/j.bmcl.2014.04.075","article-title":"In vitro screening\nof pentamidine analogs against bacterial and fungal strains","volume":"24","author":"Maciejewska","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"2026081410080010500_cit39","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1128\/AAC.34.9.1795","article-title":"Antistaphylococcal\nactivity of pentamidine","volume":"34","author":"Libman","year":"1990","journal-title":"Antimicrob. Agents\nChemother."},{"issue":"1","key":"2026081410080010500_cit40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1128\/jb.55.1.33-41.1948","article-title":"The Effect\nof Aromatic Diamidines on Bacterial Growth: II. The Antagonism of\nNucleic Acids and Polyamines","volume":"55","author":"Bichowsky-Slomnitzki","year":"1948","journal-title":"J. Bacteriol."},{"issue":"49","key":"2026081410080010500_cit41","doi-asserted-by":"publisher","DOI":"10.21037\/jlpm.2017.06.18","article-title":"Pentamidine: a drug to consider re-purposing in the\ntargeted treatment of multi-drug resistant bacterial infections","volume":"2","author":"Bean","year":"2017","journal-title":"J. Lab. Precis. Med."},{"issue":"2","key":"2026081410080010500_cit42","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0005-2760(67)90178-6","article-title":"Actions of pentamidine on the metabolism\nof Staphyfococcus\naureus","volume":"144","author":"Gale","year":"1967","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"2026081410080010500_cit43","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ijantimicag.2011.07.015","article-title":"In vitro activity of pentamidine\nagainst Tropheryma whipplei","volume":"38","author":"Rolain","year":"2011","journal-title":"Int. J. Antimicrob.\nAgents"},{"issue":"5","key":"2026081410080010500_cit44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nmicrobiol.2017.28","article-title":"Pentamidine\nsensitizes Gram-negative\npathogens to antibiotics and overcomes acquired colistin resistance","volume":"2","author":"Stokes","year":"2017","journal-title":"Nat. Microbiol."},{"key":"2026081410080010500_cit45","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s10096-020-03881-0","article-title":"Pentamidine\nsensitizes FDA-approved non-antibiotics for the inhibition of multidrug-resistant\nGram-negative pathogens","volume":"39","author":"Wu","year":"2020","journal-title":"Eur. J. Clin. Microbiol.\nInfect. Dis."},{"issue":"5","key":"2026081410080010500_cit46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2022.106582","article-title":"Repurposing\nNon-Antibiotic\nDrugs Auranofin and Pentamidine in Combination to Combat Multidrug-Resistant\nGram-Negative Bacteria","volume":"59","author":"Yu","year":"2022","journal-title":"Int. J. Antimicrob.\nAgents"},{"issue":"11","key":"2026081410080010500_cit47","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1021\/acschembio.2c00613","article-title":"Cooperative Membrane\nDamage as a Mechanism for Pentamidine\u2013Antibiotic\nMutual Sensitization","volume":"17","author":"Zhou","year":"2022","journal-title":"ACS Chem. Biol."},{"issue":"18","key":"2026081410080010500_cit48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241813812","article-title":"The Properties\nof Linezolid, Rifampicin, and Vancomycin, as Well as the Mechanism\nof Action of Pentamidine, Determine Their Synergy against Gram-Negative\nBacteria","volume":"24","author":"Tang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"2026081410080010500_cit49","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.2174\/1568026620666200704135837","article-title":"An update on\nStaphylococcus aureus NorA efflux pump inhibitors","volume":"20","author":"Monteiro","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"issue":"11","key":"2026081410080010500_cit50","doi-asserted-by":"publisher","first-page":"6394","DOI":"10.1016\/S0021-9258(19)39339-1","article-title":"A mutant of Escherichia coli defective\nin the first step of endotoxin biosynthesis","volume":"265","author":"Galloway","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"6","key":"2026081410080010500_cit51","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1128\/AAC.46.6.1845-1850.2002","article-title":"An Enterococcus faecalis ABC homologue\n(Lsa) is required for the resistance of this species to clindamycin\nand quinupristin-dalfopristin","volume":"46","author":"Singh","year":"2002","journal-title":"Antimicrob. Agents\nChemother."},{"key":"2026081410080010500_cit52","first-page":"15","article-title":"Multidrug Resistance\nEfflux","volume-title":"Symposia \u2013 Society for General\nMicrobiology","author":"Lewis","year":"1999"},{"issue":"1","key":"2026081410080010500_cit53","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1128\/JCM.41.1.5-14.2003","article-title":"Cell wall\nthickening is a common feature of vancomycin resistance\nin Staphylococcus aureus","volume":"41","author":"Cui","year":"2003","journal-title":"J. Clin. Microbiol."},{"issue":"9","key":"2026081410080010500_cit54","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1128\/AAC.44.9.2276-2285.2000","article-title":"Contribution\nof a thickened cell wall and its glutamine nonamidated component to\nthe vancomycin resistance expressed by Staphylococcus aureus Mu50","volume":"44","author":"Cui","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"2026081410080010500_cit55","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1128\/jb.94.4.1112-1123.1967","article-title":"Genetics and physiology of colicin-tolerant\nmutants of Escherichia coli","volume":"94","author":"de Zwaig","year":"1967","journal-title":"J. Bacteriol."},{"issue":"19","key":"2026081410080010500_cit56","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1128\/jb.178.19.5803-5805.1996","article-title":"Evidence\nthat TolC is required for functioning of the Mar\/AcrAB efflux pump\nof Escherichia coli","volume":"178","author":"Fralick","year":"1996","journal-title":"J. Bacteriol."},{"issue":"1","key":"2026081410080010500_cit57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/genetics\/67.1.39","article-title":"The tolC\nlocus in Escherichia coli K12","volume":"67","author":"Whitney","year":"1971","journal-title":"Genetics"},{"issue":"12","key":"2026081410080010500_cit58","doi-asserted-by":"publisher","first-page":"6602","DOI":"10.1073\/pnas.95.12.6602","article-title":"Bacteria lacking\na multidrug pump: a sensitive tool for drug discovery","volume":"95","author":"Hsieh","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"2026081410080010500_cit59","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1128\/AAC.49.5.1857-1864.2005","article-title":"Multidrug\nresistance in Staphylococcus\naureus due to overexpression of a novel multidrug and toxin extrusion\n(MATE) transport protein","volume":"49","author":"Kaatz","year":"2005","journal-title":"Antimicrob. Agents\nChemother."},{"issue":"4","key":"2026081410080010500_cit60","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1128\/AAC.50.4.1276-1281.2006","article-title":"MepR, a\nrepressor of the Staphylococcus\naureus MATE family multidrug efflux pump MepA, is a substrate-responsive\nregulatory protein","volume":"50","author":"Kaatz","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026081410080010500_cit61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2016.04.003","article-title":"Multidrug efflux pumps of Gram-positive bacteria","volume":"27","author":"Schindler","year":"2016","journal-title":"Drug Resist. Updates"},{"issue":"11","key":"2026081410080010500_cit62","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.3201\/eid2111.150452","article-title":"USA300 methicillin-resistant\nStaphylococcus\naureus, United States, 2000\u20132013","volume":"21","author":"Carrel","year":"2015","journal-title":"Emerg.\nInfect. Dis."},{"issue":"7","key":"2026081410080010500_cit63","doi-asserted-by":"publisher","first-page":"7459","DOI":"10.1021\/acs.jmedchem.4c03167","article-title":"Development\nof Membrane-Targeting Osthole Derivatives Containing\nPyridinium Quaternary Ammonium Moieties with Potent Anti-Methicillin-Resistant Staphylococcus aureus Properties","volume":"68","author":"Xu","year":"2025","journal-title":"J. Med. Chem."},{"key":"2026081410080010500_cit64","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2024.1514070","article-title":"Forecasting\nthe development of antimicrobial resistance\nof S. aureus","volume":"5","author":"Shemetov","year":"2025","journal-title":"Front. Oral Health"},{"issue":"1","key":"2026081410080010500_cit65","doi-asserted-by":"publisher","DOI":"10.1038\/srep22571","article-title":"Antibacterial\nactivity and mechanism\nof action of auranofin against multi-drug resistant bacterial pathogens","volume":"6","author":"Thangamani","year":"2016","journal-title":"Sci. Rep."},{"key":"2026081410080010500_cit66","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3389\/fmicb.2015.00750","article-title":"Repurposing celecoxib as a topical\nantimicrobial agent","volume":"6","author":"Thangamani","year":"2015","journal-title":"Front. Microbiol."},{"issue":"7","key":"2026081410080010500_cit67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133877","article-title":"Repurposing clinical\nmolecule ebselen\nto combat drug resistant pathogens","volume":"10","author":"Thangamani","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"2026081410080010500_cit68","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1369-5274(02)00293-X","article-title":"Caenorhabditis elegans as a host\nfor the study of host\u2013pathogen\ninteractions","volume":"5","author":"Aballay","year":"2002","journal-title":"Curr. Opin. Microbiol."},{"key":"2026081410080010500_cit69","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/978-1-59745-570-1_24","article-title":"Models of Caenorhabditis elegans infection by bacterial\nand fungal pathogens","author":"Powell","year":"2008","journal-title":"Innate Immun."},{"issue":"40","key":"2026081410080010500_cit70","doi-asserted-by":"publisher","first-page":"16169","DOI":"10.1073\/pnas.1311066110","article-title":"Bacterial cytological\nprofiling rapidly identifies the cellular pathways targeted by antibacterial\nmolecules","volume":"110","author":"Nonejuie","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"2026081410080010500_cit71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48898-4","article-title":"Gram-negative\nsynergy and mechanism of action of alkynyl bisbenzimidazoles","volume":"9","author":"Chamberlin","year":"2019","journal-title":"Sci. Rep."},{"key":"2026081410080010500_cit72","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03138-22","article-title":"When Combined with\nPentamidine, Originally Ineffective Linezolid Becomes Active in Carbapenem-Resistant\nEnterobacteriaceae","volume":"11","author":"Tang","year":"2023","journal-title":"Microbiol. Spectrum"},{"issue":"4","key":"2026081410080010500_cit73","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.230020","article-title":"Escaping ESKAPE\nresistance: In vitro and in silico studies of multifunctional carbamimidoyl-tethered\nindoles against antibiotic-resistant bacteria","volume":"10","author":"Gulia","year":"2023","journal-title":"R. Soc. Open Sci."},{"issue":"W1","key":"2026081410080010500_cit74","doi-asserted-by":"publisher","first-page":"W566","DOI":"10.1093\/nar\/gkv468","article-title":"ClustVis: a web tool\nfor visualizing clustering of multivariate data\nusing Principal Component Analysis and heatmap","volume":"43","author":"Metsalu","year":"2015","journal-title":"Nucleic Acids Res."}],"container-title":["ACS Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsinfecdis.6c00572","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article-pdf\/12\/8\/2874\/66426955\/acsinfecdis.6c00572.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article-pdf\/12\/8\/2874\/66426955\/acsinfecdis.6c00572.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:33:36Z","timestamp":1786718016000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article\/12\/8\/2874\/5247109\/Activity-of-Thiourea-Linked-Diamidines-against"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":74,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,5]]},"published-print":{"date-parts":[[2026,8,14]]}},"URL":"https:\/\/doi.org\/10.1021\/acsinfecdis.6c00572","relation":{},"ISSN":["2373-8227"],"issn-type":[{"value":"2373-8227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]}}}